Right now the price per share is 2,76$, In this post we are going to talk about the listed company OncoCyte Corp, its leaders are Mitchell Stuart Levine (Chief Financial Officer), Ronald Asbury Andrews (President, Chief Executive Officer & Director), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 2,77$ moving between 2,72$ and 2,83$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
